David Ørsted, Denmark



David Ørsted works as a Global Medical Director for Novo Nordisk A/S. David joined Novo Nordisk in 2014 and is responsible for scientific communication of data from Novo Nordisk outcomes trials and activities within new therapy areas such as diabetic nephropathy and atherosclerosis. 

He has a clinical background in internal medicine after obtaining his medical degree from the University of Copenhagen and has attended the Karolinska Institute and Weill Medical College, Cornell University.

David earned his PhD in epidemiology at the University of Copenhagen in 2013.